| 000 | 01506 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516032712.0 | ||
| 264 | 0 | _c20111031 | |
| 008 | 201110s 0 0 eng d | ||
| 022 | _a1538-7836 | ||
| 024 | 7 |
_a10.1111/j.1538-7836.2011.04281.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDreyfus, M | |
| 245 | 0 | 0 |
_aSuccessful long-term replacement therapy with FXIII concentrate (Fibrogammin(®) P) for severe congenital factor XIII deficiency: a prospective multicentre study. _h[electronic resource] |
| 260 |
_bJournal of thrombosis and haemostasis : JTH _cJun 2011 |
||
| 300 |
_a1264-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Letter; Multicenter Study | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFactor XIII |
| 650 | 0 | 4 |
_aFactor XIII Deficiency _xcongenital |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolysin _xtherapeutic use |
| 650 | 0 | 4 | _aFibrinolytic Agents |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBarrois, D | |
| 700 | 1 | _aBorg, J-Y | |
| 700 | 1 | _aClaeyssens, S | |
| 700 | 1 | _aTorchet, M-F | |
| 700 | 1 | _aArnuti, B | |
| 700 | 1 | _aPautard, B | |
| 773 | 0 |
_tJournal of thrombosis and haemostasis : JTH _gvol. 9 _gno. 6 _gp. 1264-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1538-7836.2011.04281.x _zAvailable from publisher's website |
| 999 |
_c20748018 _d20748018 |
||